Introduction

The G8 Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market.
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market.
* Leading company profiles reveal details of key pharmaceuticals market players' G8 operations and financial performance.
* Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts.
* Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country.

Highlights

The G8 countries contributed $538.9 billion in 2013 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.5% between 2009 and 2013. The G8 countries are expected to reach a value of $637.6 billion in 2018, with a CAGR of 3.4% over the 2013-18 period.
Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $284.6 billion in 2013. This was followed by Japan and Germany, with a value of $94.3 and $35.6 billion, respectively.
The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $344.0 billion in 2016, followed by Japan and Germany with expected values of $110.6 and $39.4 billion, respectively.

Your key questions answered

* What was the size of the G8 pharmaceuticals market by value in 2013?
* What will be the size of the G8 pharmaceuticals market in 2018?
* What factors are affecting the strength of competition in the G8 pharmaceuticals market?
* How has the market performed over the last five years?

Table Of Contents

Pharmaceuticals: Global Group of Eight (G8) Industry Guide
INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
Definitions
GROUP OF EIGHT (G8) PHARMACEUTICALS
Industry Outlook
PHARMACEUTICALS IN CANADA
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN FRANCE
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN GERMANY
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN ITALY
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN JAPAN
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN RUSSIA
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN THE UNITED KINGDOM
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN THE UNITED STATES
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
COMPANY PROFILES
Leading companies
APPENDIX
Methodology

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with ...

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered ...

Opportunity in the Indian Pharmaceutical Packaging Market - 2015 ; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Pharmaceutical Packaging Market - 2015 ; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 6 000
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Opportunity in the Indian Pharmaceutical Packaging current market scenario, structure and practices. In depth market scenario includes; - All India pharmaceutical ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.